Item 5. Market for Registrant’s Common Equity
Item 5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Market Information
Our common stock trades on
the NASDAQ Capital Market under the symbol “ATOM”.
Holders of Record
As of February 19, 2026, there were 106 holders
of record of our common stock.
Dividend Policy
We have never declared or
paid cash dividends on our common stock. We presently intend to retain earnings, if any, to finance the operation and expansion of our
business.
Equity Compensation Plan Information
Our 2007 Equity Incentive
Plan, or 2007 Plan, expired in March 2017, however all options outstanding at the time of the expiration remained outstanding
and exercisable by their term.
In May 2017, we established
our 2017 Stock Incentive Plan, or 2017 Plan. The 2017 Plan provides for the grant of non-qualified stock options and incentive stock options
to purchase shares of our common stock and for the grant of restricted and unrestricted share grants. We have reserved a total of 3,750,000
shares of common stock for issuance under the 2017 Plan. All employees, officers, directors, consultants, advisors and other persons who
provide services to us or any of our subsidiaries are eligible to receive incentive awards under the 2017 Plan. As of December 31, 2025,
awards of 3,735,394 shares of common stock had been granted under the 2017 Plan, net of forfeited restricted stock and option awards and
a total of 14,606 shares of common stock are reserved for issuance.
In May 2023, we established
our 2023 Stock Incentive Plan, or 2023 Plan. The 2023 Plan provides for the grant of non-qualified stock options and incentive stock options
to purchase shares of our common stock and for the grant of restricted and unrestricted share grants. We have reserved a total of 2,000,000
shares of common stock for issuance under the 2023 Plan. In May 2025, our shareholders approved an amendment to the 2023 Plan, adding
an additional 1,750,000 shares to this plan. All employees, officers, directors, consultants, advisors and other persons who provide services
to us or any of our subsidiaries are eligible to receive incentive awards under the 2023 Plan. As of December 31, 2025, awards of 1,525,908
shares of common stock had been granted under the 2023 Plan, net of forfeited restricted stock and option awards and a total of 2,224,092
shares of common stock are reserved for issuance.
20
The following table sets forth
certain information as of December 31, 2025 about our stock plans under which our equity securities are authorized for issuance.
Plan Category
Number of Securities to be Issued Upon Exercise of Outstanding Options and Rights
(a) (2)(3)
Weighted-Average Exercise Price of Outstanding Options (1)
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected In Column (a) (4)
Equity compensation plans approved by security holders
3,514,485
$ 6.53
2,238,698
Equity compensation plans not approved by security holders
–
–
–
Total
3,514,485
$ 6.53
2,238,698
(1) Restricted stock units issued under our equity compensation plans do not require payment by the recipient
to us at the time of vesting. As such, the weighted-average exercise price does not take these awards into account and only takes into
account outstanding stock options.
(2) Includes 2,906,527 shares of our common stock underlying stock options issued under the 2023 Plan, 2017
Plan and 2007 Plan.
(3) Includes 386,438 shares of common stock underlying time-based restricted stock units and 221,520 shares
of common stock underlying performance-based restricted stock units issuable assuming performance at target under the 2023 Plan and 2027
Plan.
(4) Includes awards issuable under the 2023 Plan and 2017 Plan.
Item 6.
Reserved